In our previous study, we identified that NK-exos regulate HCC targeting and cell death through two mechanisms: membrane fusion (perforin and granzyme B) and ligand–receptor interaction (FasL and TRAIL), both in vitro and in vivo. The gene discussed is PRF1; the disease is hepatocellular carcinoma.